News › Clinical Practice, Industry News, Patient Care

FDA Approves Juvéderm Voluma XC for Enhancement of the Chin Region

June 15, 2020

Allergan Aesthetics, an AbbVie company, announced the FDA approval of Juvéderm Voluma XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21.1 The Juvéderm collection of fillers has a broad portfolio of specifically tailored treatment options, and this latest approval marks its fifth approved indication in the U.S.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Galderma Opens New U.S. and Latin America Headquarters in Miami
    • Raging Agency Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Medical Marketing Whiz Announces Partnership With Boulevard to Help Med Spas and Wellness Clinics Streamline Operations
    • ByrdAdatto Attorneys Recognized in the 2027 Edition of Best Lawyers
    • RHA Redensity Eye Receives FDA Approval for Undereye Hollowing
Advertisement